Page 27 - Demo

General introduction25160. Hearing loss prevalence and years lived with disability, 1990-2019: findings from the GlobalBurden of Disease Study 2019. Lancet. Mar 13 2021;397(10278):996-1009. doi:10.1016/s0140-6736(21)00516-x61. Gates GA, Mills JH. Presbycusis. The Lancet. 2005/09/24/ 2005;366(9491):1111-1120. doi:https://doi.org/10.1016/S0140-6736(05)67423-562. Huang Q, Tang J. Age-related hearing loss or presbycusis. Eur Arch Otorhinolaryngol. Aug 2010;267(8):1179-91. doi:10.1007/s00405-010-1270-763. Persson C, Friman V, Óskarsdóttir S, Jönsson R. Speech and hearing in adults with 22q11.2 deletion syndrome. Am J Med Genet A. Dec 2012;158a(12):3071-9. doi:10.1002/ajmg.a.3558964. Verheij E, Kist AL, Mink van der Molen AB, et al. Otologic and audiologic findings in 22q11.2deletion syndrome. Eur Arch Otorhinolaryngol. Feb 2017;274(2):765-771. doi:10.1007/s00405-016-4365-y65. Zarchi O, Attias J, Raveh E, Basel-Vanagaite L, Saporta L, Gothelf D. A comparative study of hearing loss in two microdeletion syndromes: velocardiofacial (22q11.2 deletion) and Williams (7q11.23 deletion) syndromes. J Pediatr. Feb 2011;158(2):301-6. doi:10.1016/j.jpeds.2010.07.05666. Van Eynde C, Swillen A, Lambeens E, et al. Prevalence and Nature of Hearing Loss in 22q11.2 Deletion Syndrome. J Speech Lang Hear Res. Jun 1 2016;59(3):583-9. doi:10.1044/2015_jslhr-h-15-009867. Verheij E, Derks LSM, Stegeman I, Thomeer H. Prevalence of hearing loss and clinical otologic manifestations in patients with 22q11.2 deletion syndrome: A literature review. Clin Otolaryngol. Dec 2017;42(6):1319-1328. doi:10.1111/coa.1287468. Willaert A, Van Eynde C, Verhaert N, et al. Vestibular dysfunction is a manifestation of 22q11.2 deletion syndrome. Am J Med Genet A. Mar 2019;179(3):448-454. doi:10.1002/ajmg.a.769. van Splunder J, Stilma JS, Bernsen RM, Arentz TG, Evenhuis HM. Refractive errors and visual impairment in 900 adults with intellectual disabilities in the Netherlands. Acta Ophthalmol Scand. Apr 2003;81(2):123-9. doi:10.1034/j.1600-0420.2003.00035.x70. Hashemi H, Fotouhi A, Yekta A, Pakzad R, Ostadimoghaddam H, Khabazkhoob M. Global and regional estimates of prevalence of refractive errors: Systematic review and meta-analysis. J Curr Ophthalmol. Mar 2018;30(1):3-22. doi:10.1016/j.joco.2017.08.00971. Forbes BJ, Binenbaum G, Edmond JC, DeLarato N, McDonald-McGinn DM, Zackai EH. Ocular findings in the chromosome 22q11.2 deletion syndrome. J aapos. Apr 2007;11(2):179-82. doi:10.1016/j.jaapos.2006.08.00672. Binenbaum G, McDonald-McGinn DM, Zackai EH, et al. Sclerocornea associated with the chromosome 22q11.2 deletion syndrome. American journal of medical genetics Part A. 2008;146A(7):904-909. doi:10.1002/ajmg.a.3215673. Gokturk B, Topcu-Yilmaz P, Bozkurt B, et al. Ocular Findings in Children With 22q11.2 Deletion Syndrome. J Pediatr Ophthalmol Strabismus. Jul 1 2016;53(4):218-22. doi:10.3928/01913913-20160427-0174. Casteels I, Casaer P, Gewillig M, Swillen A, Devriendt K. Ocular findings in children with amicrodeletion in chromosome 22q11.2. Eur J Pediatr. Jul 2008;167(7):751-5. doi:10.1007/s00431-007-0582-075. Okazaki T, Hifumi T, Ibata T, et al. Recurrent convulsions, hypocalcemia, and hypoparathyroidism related to delayed diagnosis of 22q11.2 deletion syndrome in a middle-aged man. Acute Med Surg. Oct 2016;3(4):397-399. doi:10.1002/ams2.21676. Moss HE. Retinal Vascular Changes are a Marker for Cerebral Vascular Diseases. Curr Neurol Neurosci Rep. Jul 2015;15(7):40. doi:10.1007/s11910-015-0561-177. Patton N, Aslam T, Macgillivray T, Pattie A, Deary IJ, Dhillon B. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J Anat. Apr 2005;206(4):319-48. doi:10.1111/j.1469-7580.2005.00395.x78. Appaji A, Nagendra B, Chako DM, et al. Retinal vascular abnormalities in schizophrenia and bipolar disorder: A window to the brain. Bipolar Disord. Nov 2019;21(7):634-641. doi:10.1111/bdi.12779